These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16422304)

  • 1. Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
    Pan SC; Hsieh SM; Chang SC; Lee HT; Chen YC
    Med Mycol; 2005 Dec; 43(8):731-4. PubMed ID: 16422304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
    Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
    Fanci R
    J Chemother; 2009 Feb; 21(1):105-7. PubMed ID: 19297283
    [No Abstract]   [Full Text] [Related]  

  • 4. Candida inferior vena cava filter infection and septic thrombophlebitis.
    Meda MS; Lopez AJ; Guyot A
    Br J Radiol; 2007 Feb; 80(950):e48-9. PubMed ID: 17495055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin.
    Olver WJ; Scott F; Shankland GS
    Med Mycol; 2006 Nov; 44(7):655-7. PubMed ID: 17071561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
    Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
    J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
    Hakki M; Staab JF; Marr KA
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
    Pemán J; Jarque I; Bosch M; Cantón E; Salavert M; de Llanos R; Molina A
    J Clin Microbiol; 2006 May; 44(5):1912-4. PubMed ID: 16672439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal pharmacotherapy for neonatal candidiasis.
    Bliss JM; Wellington M; Gigliotti F
    Semin Perinatol; 2003 Oct; 27(5):365-74. PubMed ID: 14626500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate.
    Yalaz M; Akisu M; Hilmioglu S; Calkavur S; Cakmak B; Kultursay N
    Mycoses; 2006 May; 49(3):242-5. PubMed ID: 16681818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin for refractory candidemia in neonates.
    Manzar S; Kamat M; Pyati S
    Pediatr Infect Dis J; 2006 Mar; 25(3):282-3. PubMed ID: 16511405
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifungal resistance: the clinical front.
    Perfect JR
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
    McGee WT; Tereso GJ
    Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
    Manfredi R; Sabbatani S
    Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 16. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
    López-Ciudad V; Castro-Orjales MJ; León C; Sanz-Rodríguez C; de la Torre-Fernández MJ; Pérez de Juan-Romero MA; Collell-Llach MD; Díaz-López MD
    BMC Infect Dis; 2006 Apr; 6():73. PubMed ID: 16608509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin therapy of neonates with invasive candidiasis.
    Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
    Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature.
    Pelletier R; Alarie I; Lagacé R; Walsh TJ
    Med Mycol; 2005 Sep; 43(6):559-64. PubMed ID: 16320498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of micafungin for the treatment of candidemia.
    Andes D; Safdar N
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):662-4. PubMed ID: 16247615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.